n-formyl-13-dihydrocarminomycin has been researched along with lumefantrine in 1 studies
| Studies (n-formyl-13-dihydrocarminomycin) | Trials (n-formyl-13-dihydrocarminomycin) | Recent Studies (post-2010) (n-formyl-13-dihydrocarminomycin) | Studies (lumefantrine) | Trials (lumefantrine) | Recent Studies (post-2010) (lumefantrine) |
|---|---|---|---|---|---|
| 22 | 2 | 20 | 487 | 123 | 298 |
| Protein | Taxonomy | n-formyl-13-dihydrocarminomycin (IC50) | lumefantrine (IC50) |
|---|---|---|---|
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 5.5351 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amambua-Ngwa, A; Dugassa, S; Golassa, L; Jawara, A; Oboh, M; Oriero, E; Tadele, G | 1 |
1 other study(ies) available for n-formyl-13-dihydrocarminomycin and lumefantrine
| Article | Year |
|---|---|
Clinical isolates of uncomplicated falciparum malaria from high and low malaria transmission areas show distinct pfcrt and pfmdr1 polymorphisms in western Ethiopia.
Topics: Antimalarials; Artemether; Artemether, Lumefantrine Drug Combination; Chloroquine; Drug Resistance; Ethiopia; Humans; Lumefantrine; Malaria; Malaria, Falciparum; Multidrug Resistance-Associated Proteins; Plasmodium falciparum; Polymorphism, Single Nucleotide; Protozoan Proteins | 2023 |